Doenças do Pâncreas: Artigos de Revisão Online (Pancreatic Diseases: Review Articles)
■ Risk factor for rate of relapse of steroid maintenance therapy in patient with autoimune pancreatitis: systematic review and meta-analysis
M Tacellii, C Celsa, B Magro et al
Clinical Gastroenterology and Hepatology 2019, vol 17 (6): 1061-1072
https://www.cghjournal.org/article/S1542-3565(18)31089-9/fulltext
■ Chronic pancreatitis: diagnosis and treatment
K Barry,
Am Fam Physician 2018, vol 97 (6): 385-393
https://www.aafp.org/afp/2018/0315/p385.html
■ Chronic pancreatitis: current status and challenges for prevention and treatment
D Lew, E Afghani, S Pandol
Dig Dis Sci 2017, vol 62 (7): 1702-1712
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507364/
■ United European Gastroenterology evidence based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU
J Matthias Löhr, E Dominguez-Munoz, J Rosendahl et al
United European Gastroenterology Journal 2017, Vol. 5(2) 153–199
https://journals.sagepub.com/doi/pdf/10.1177/2050640616684695
■ Pancreatic necrosis: complications and changing trend of treatment
Mamoon Ur Rashid, Ishtiaq Hussain, Sundas Jehanzeb et al
World J Gastrointest Surg. 2019 Apr 27; 11(4): 198–217.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513789/
■ Endoscopic ultrasound-guided ablation of pancreatic cystic neoplasm: ready for prime time?
Andrew Ofosu, Daryl Ramai, Douglas G. Adler
Ann Gastroenterol. 2019 Jan-Feb; 32(1): 39–45
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302202/
■ Endoscopic ultrasound-guided ablation of pancreatic cysts
William R. Brugge
Gastroenterol Hepatol (N Y) 2018 Oct; 14(10): 602–604.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366241/
■ Gas embolism durign endocopic retrograde cholangiopancreatography: diagnosis and management
Gandhi Lanke, Douglas G. Adler
Ann Gastroenterol. 2019 Mar-Apr; 32(2): 156–167
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394273/
■ Moderately severe and severe acute pancreatitis: a systematic review of the outcome in the USA and European Union-%
Grammati Sarri, Yelan Guo, Ike Iheanacho, Jorge Puelles
BMJ Open Gastroenterol. 2019; 6(1): e000248
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398872/
■ A review of prevention of post-ERCP pancreatitis
Shannon J. Morales, Kartik Sampath, Timothy B. Gardner
Gastroenterol Hepatol (N Y) 2018 May; 14(5): 286–292.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034611/
■ A comprehensive approach to preventing pancreatitis following endoscopic retrograde cholangiopancreatography
Timothy B. Gardner
Gastroenterol Hepatol (N Y) 2018 Nov; 14(11): 668–670.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284346/
■ European evidence-based guidelines on pancreatic cystic neoplasms
The European Study Group on Cystic Tumours of the Pancreas
Gut. 2018 May; 67(5): 789–80
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890653/
■ Management of pancreatic head adenocarcinoma: From where to where?
Kemal Dolay, Fatma Umit Malya, Sami Akbulut
World J Gastrointest Surg. 2019 Mar 27; 11(3): 143–154.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478601/
■ Molecular therapeutic strategies targeting pancreatic cancer induced cachexia
Anastasiya Yakovenko, Miles Cameron, Jose Gilberto Trevino
World J Gastrointest Surg. 2018 Dec 27; 10(9): 95–106
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314860/
■ Contemporary management of borderline resectable pancreatic ductal adenocarcinoma
Kyriaki Lekka, Evanthia Tzitzi, Alexander Giakoustidis et al
Ann Hepatobiliary Pancreat Surg. 2019 May; 23(2): 97–108
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558121/
■ Current role of palliative interventions in advanced pancreatic cancer
Chelsey C Ciambella, Rachel E Beard, Thomas J Miner
World J Gastrointest Surg. 2018 Oct 27; 10(7): 75–83
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212542/
■ A contenporary review of the treatment landscape and the role of predictive and prognostic biomarkers in pancreatic adenocarcinoma
Irene S. Yu, Winson Y. Cheung
Canadina Journal of Gastroenterology and Hepatology 2018, Article ID 18633535, 10 pages
https://www.hindawi.com/journals/cjgh/2018/1863535/
■ The use of biomarkers in early diagnosis of pancreatic cancer
Lumir Kunovsky, Pavla Tesarikova, Zdenek Kala et al
Can J Gastroenterol Hepatol. 2018; 2018: 5389820
https://www.hindawi.com/journals/cjgh/2018/5389820/
■ Pain in pancreatic ductal adenocarcinoma: a multidisciplinary, international guidelines for optimized management
A M Drewes, C M Campbell, G O Ceyhan et al
Pancreatology 2018, vol 18 (4): 446-457
https://www.sciencedirect.com/science/article/pii/S1424390318300759
■ International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017
S Isaji, S Mizuno, J A Windsor et al
Pancreatology 2018, vol 18 (1): 2-11
https://www.sciencedirect.com/science/article/pii/S1424390317308864
■ Combination immunotherpay approaches for pancreatic cancer treatment
Xianliang Cheng, Gang Zhao, Yunqi Zhao
Can J Gastroenterol Hepatol. 2018; 2018: 6240467
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863289/
■ Practical management of toxicities associated with targeted therapies for advanced gastroenteropancreatic neuroendocrine tumors
Pieter-Jan Cuyle, Hans Prenen
Ann Gastroenterol. 2018 Mar-Apr; 31(2): 140–150
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825944/
■ Pitfalls for laparoscopic pancreaticoduodenectomy: need for a stepwise approach
Jonathan Geograpo Navarro, Chang Moo Kang
Ann Gastroenterol Surg. 2019 May; 3(3): 254–268
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524087/
■ Immunotherapy for pancreatic cancer: barriers and breakthroughs
Robert J. Torphy, Yuwen Zhu, Richard D. Schulick
Ann Gastroenterol Surg. 2018 Jul; 2(4): 274–28
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036358/
■ Surgery for pancreatic cancer after neoadjuvant treatment
Thilo Hackert
Ann Gastroenterol Surg. 2018 Nov; 2(6): 413–418
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236102/
■ The adult pancreas in trauma and disease
Alfredo E. Walker
Acad Forensic Pathol. 2018 Jun; 8(2): 192–218
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490126/
■ Psychometric evaluation of a patient-reported outcome measure in pancreatic exocrine insufficiency (PEI)
C D Johnson, N Williamson, G J van Solingen et al
Pancreatology 2019, vol 19 (1): 182-190
https://www.sciencedirect.com/science/article/pii/S1424390318307609
■ Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases?
R C Lee, H Kanhere, M Trochsler et al
World J Gastrointest Oncol 2018, vol 10 (8): 211-220
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107475/
■ Histo-molecular oncogenesis of pancreatic cancer: From precancerous lesions to invasive ductal adenocarcinoma
G Riva, A Pea, C Pilati et al
World J Gastrointest Oncol 2018, vol 10 (10): 317-327
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198304/
■ Dr Paulo Fernando Leite
Cardiologia/Prevenção Cardiovascular
Estratificação de Risco Cardiovascular
Novo endereço:
Consultório: Rua Padre Rolim 815/sala 815
Tel: 33245518 (Consulta Particular/Unimed)
– Centro Médico Unimed BH/Contagem/Pedro I
Belo Horizonte/MG/Brasil
CRMMG: 7026
Email: pfleite1873@gmail.com